- Home
- AAP vs APLS Comparison
AAP vs APLS Comparison
Compare AAP & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- APLS
- Stock Information
- Founded
- AAP 1929
- APLS 2009
- Country
- AAP United States
- APLS United States
- Employees
- AAP N/A
- APLS N/A
- Industry
- AAP Auto & Home Supply Stores
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- AAP Consumer Discretionary
- APLS Health Care
- Exchange
- AAP Nasdaq
- APLS Nasdaq
- Market Cap
- AAP 3.3B
- APLS 2.9B
- IPO Year
- AAP N/A
- APLS 2017
- Fundamental
- Price
- AAP $56.30
- APLS $30.10
- Analyst Decision
- AAP Hold
- APLS Buy
- Analyst Count
- AAP 19
- APLS 19
- Target Price
- AAP $52.45
- APLS $33.63
- AVG Volume (30 Days)
- AAP 1.6M
- APLS 2.4M
- Earning Date
- AAP 10-30-2025
- APLS 10-30-2025
- Dividend Yield
- AAP 1.75%
- APLS N/A
- EPS Growth
- AAP N/A
- APLS N/A
- EPS
- AAP N/A
- APLS N/A
- Revenue
- AAP $8,737,327,000.00
- APLS $754,649,000.00
- Revenue This Year
- AAP N/A
- APLS $24.62
- Revenue Next Year
- AAP $1.00
- APLS N/A
- P/E Ratio
- AAP N/A
- APLS N/A
- Revenue Growth
- AAP N/A
- APLS 20.02
- 52 Week Low
- AAP $28.89
- APLS $16.10
- 52 Week High
- AAP $70.00
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- AAP 49.96
- APLS 70.16
- Support Level
- AAP $52.81
- APLS $23.85
- Resistance Level
- AAP $57.73
- APLS $30.48
- Average True Range (ATR)
- AAP 2.24
- APLS 1.23
- MACD
- AAP 0.42
- APLS 0.55
- Stochastic Oscillator
- AAP 83.37
- APLS 94.78
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.